{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:05:51Z","timestamp":1784196351892,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-27448-4","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:46:09Z","timestamp":1777452369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effective mHealth interventions to improve tuberculosis treatment adherence in Asia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Shamal","family":"Kankawale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amruta","family":"Chutke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"27448_CR1","doi-asserted-by":"publisher","unstructured":"Haley CA, Schlossberg D. Treatment of Latent Tuberculosis Infection. Microbiol Spectr. 2017;5(2). https:\/\/doi.org\/10.1128\/microbiolspec.tnmi7-0039-2016.","DOI":"10.1128\/microbiolspec.tnmi7-0039-2016"},{"key":"27448_CR2","doi-asserted-by":"publisher","first-page":"e49741","DOI":"10.2196\/49741","volume":"11","author":"S Lee","year":"2023","unstructured":"Lee S, Rajaguru V, Baek JS, Shin J, Park Y. Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review. JMIR MHealth UHealth. 2023;11:e49741\u201349741. https:\/\/doi.org\/10.2196\/49741.","journal-title":"JMIR MHealth UHealth"},{"key":"27448_CR3","doi-asserted-by":"publisher","unstructured":"Bahukudumbi S, Chilala CI, Foster N, Patel B, Mohamed MS, Zary M et al. Contextual factors influencing implementation of tuberculosis digital adherence technologies: A scoping review guided by the RE-AIM framework. BMJ Glob Health. 2025;10(2). Located at: Scopus. https:\/\/doi.org\/10.1136\/bmjgh-2024-016608.","DOI":"10.1136\/bmjgh-2024-016608"},{"issue":"1","key":"27448_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijtb.2023.03.001","volume":"71","author":"RA Davis","year":"2024","unstructured":"Davis RA, Leavitt HB, Singh A, Fanouraki E, Yen RW, Bratches RW. Examining interventions that aim to enhance TB treatment adherence in Southeast Asia: A systematic review and meta-analysis. Indian J Tuberc. 2024;71(1):48\u201363. https:\/\/doi.org\/10.1016\/j.ijtb.2023.03.001. PubMed PMID: 38296391.","journal-title":"Indian J Tuberc"},{"issue":"1","key":"27448_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41533-020-0179-x","volume":"30","author":"IS Pradipta","year":"2020","unstructured":"Pradipta IS, Houtsma D, Van Boven JFM, Alffenaar JWC, Hak E. Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. Npj Prim Care Respir Med. 2020;30(1):21. https:\/\/doi.org\/10.1038\/s41533-020-0179-x.","journal-title":"Npj Prim Care Respir Med"},{"issue":"1","key":"27448_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/ijph.IJPH_879_20","volume":"65","author":"S Santra","year":"2021","unstructured":"Santra S, Garg S, Basu S, Sharma N, Singh MM, Khanna A. The effect of a mhealth intervention on anti-tuberculosis medication adherence in Delhi, India: A quasi-experimental study. Indian J Public Health. 2021;65(1):34\u20138. https:\/\/doi.org\/10.4103\/ijph.IJPH_879_20. Located at: Ovid MEDLINE(R) <\u20092021>.","journal-title":"Indian J Public Health"},{"key":"27448_CR7","first-page":"1","volume-title":"MDR\/RR-TB), 2021\u20132025: Background Document","author":"WHO Global Lists of High Burden Countries for Tuberculosis (TB)","year":"2021","unstructured":"WHO Global Lists of High Burden Countries for Tuberculosis (TB). TB\/HIV and Multidrug. In: rifampicin-Resistant TB, editor. MDR\/RR-TB), 2021\u20132025: Background Document. 1st ed. Geneva: World Health Organization; 2021. p. 1.","edition":"1"},{"issue":"15","key":"27448_CR8","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.3390\/ijerph17155626","volume":"17","author":"ZS Nezenega","year":"2020","unstructured":"Nezenega ZS, Perimal-Lewis L, Maeder AJ. Factors Influencing Patient Adherence to Tuberculosis Treatment in Ethiopia: A Literature Review. Int J Environ Res Public Health. 2020;17(15):5626. https:\/\/doi.org\/10.3390\/ijerph17155626.","journal-title":"Int J Environ Res Public Health"},{"key":"27448_CR9","doi-asserted-by":"publisher","unstructured":"Tola HH, Shojaeizadeh D, Tol A, Garmaroudi G, Yekaninejad MS, Kebede A et al. Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial. Fernandez-Reyes D, editor. PLOS ONE. 2016;11(5):e0155147. https:\/\/doi.org\/10.1371\/journal.pone.0155147.","DOI":"10.1371\/journal.pone.0155147"},{"issue":"2","key":"27448_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.9745\/GHSP-D-16-00018","volume":"4","author":"MJ DiStefano","year":"2016","unstructured":"DiStefano MJ, Schmidt H. mHealth for Tuberculosis Treatment Adherence: A Framework to Guide Ethical Planning, Implementation, and Evaluation. Glob Health Sci Pract. 2016;4(2):211\u201321. https:\/\/doi.org\/10.9745\/GHSP-D-16-00018.","journal-title":"Glob Health Sci Pract"},{"key":"27448_CR11","unstructured":"WHO consolidated guidelines on tuberculosis. module 4: treatment: drug-susceptible tuberculosis treatment. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240048126. Cited 7 Jul 2025."},{"issue":"7","key":"27448_CR12","doi-asserted-by":"publisher","first-page":"e1002595","DOI":"10.1371\/journal.pmed.1002595","volume":"15","author":"N Alipanah","year":"2018","unstructured":"Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLOS Med. 2018;15(7):e1002595. https:\/\/doi.org\/10.1371\/journal.pmed.1002595.","journal-title":"PLOS Med"},{"key":"27448_CR13","doi-asserted-by":"publisher","unstructured":"Laksono EB, Johan A, Erawati M, The utilization of mobile-health, intervention in improving treatment compliance behavior in tuberculosis patients. Nurse Health. 2022;11(2). https:\/\/doi.org\/10.36720\/nhjk.v11i2.339.","DOI":"10.36720\/nhjk.v11i2.339"},{"issue":"1","key":"27448_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12889-019-7892-9","volume":"20","author":"KK Bommakanti","year":"2020","unstructured":"Bommakanti KK, Smith LL, Liu L, Do D, Cuevas-Mota J, Collins K, et al. Requiring smartphone ownership for mHealth interventions: who could be left out? BMC Public Health. 2020;20(1):81. Located at: Ovid MEDLINE(R. ). https:\/\/doi.org\/10.1186\/s12889-019-7892-9.","journal-title":"BMC Public Health"},{"key":"27448_CR15","doi-asserted-by":"publisher","unstructured":"Areas Lisboa Netto T, Diniz BD, Odutola P, Dantas CR, De Freitas MCFLC, Hefford PM et al. Video-observed therapy (VOT) vs directly observed therapy (DOT) for tuberculosis treatment: A systematic review on adherence, cost of treatment observation, time spent observing treatment and patient satisfaction. Pappas G, editor. PLoS Negl Trop Dis. 2024;18(10):e0012565. https:\/\/doi.org\/10.1371\/journal.pntd.0012565.","DOI":"10.1371\/journal.pntd.0012565"},{"issue":"2","key":"27448_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wmh3.337","volume":"12","author":"D Das Gupta","year":"2020","unstructured":"Das Gupta D, Patel A, Saxena D, Koizumi N, Trivedi P, Patel K, et al. Choice-Based Reminder Cues: Findings From an mHealth Study to Improve Tuberculosis (TB) Treatment Adherence Among the Urban Poor in India. World Med Health Policy. 2020;12(2):163\u201381. Located at: Scopus. https:\/\/doi.org\/10.1002\/wmh3.337.","journal-title":"World Med Health Policy"},{"issue":"6","key":"27448_CR17","doi-asserted-by":"publisher","first-page":"e052633","DOI":"10.1136\/bmjopen-2021-052633","volume":"12","author":"K Velen","year":"2022","unstructured":"Velen K, Nguyen VN, Nguyen BH, Dang T, Nguyen HA, Vu DH, et al. Harnessing new mHealth technologies to Strengthen the Management of Multidrug-Resistant Tuberculosis in Vietnam (V-SMART trial): a protocol for a randomised controlled trial. BMJ Open. 2022;12(6):e052633. https:\/\/doi.org\/10.1136\/bmjopen-2021-052633. PubMed PMID: 35732397.","journal-title":"BMJ Open"},{"key":"27448_CR18","unstructured":"Prasetyo YA, Preechawong S, Yunibhand J, Effect of a tuberculosis. Health promotion program on medication adherence among tuberculosis patients. https:\/\/www.thaiscience.info\/Journals\/Article\/JHRE\/10972211.pdf."},{"key":"27448_CR19","unstructured":"World Bank Blogs. World Bank country classifications by income level for 2024\u20132025. Available from: https:\/\/blogs.worldbank.org\/en\/opendata\/world-bank-country-classifications-by-income-level-for-2024-2025. Cited 7 Jul 2025."},{"key":"27448_CR20","unstructured":"PRISMA statement. PRISMA statement. Available from: https:\/\/www.prisma-statement.org. Cited 11 Jun 2025."},{"key":"27448_CR21","unstructured":"Kulkarni M, Golechha S, Raj R, Sreedharan JK, Bhardwaj A, Rathod S et al. Predicting Treatment Adherence of Tuberculosis Patients at Scale. https:\/\/ui.adsabs.harvard.edu\/abs\/2022arXiv221102943K\/abstract."},{"key":"27448_CR22","unstructured":"Faolan CP. Zotero [Mac 13.4.1]. India: Corporation for Digital Scholarship; 2026. Available from: https:\/\/www.zotero.org\/.\u00a0Accessed on: 18 December 2025."},{"issue":"1","key":"27448_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"27448_CR24","unstructured":"RoB 2. A revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias. Available from: https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. Cited 7 Jul 2025."},{"key":"27448_CR25","unstructured":"Cochrane Handbook for Systematic Reviews. of Interventions version 6.5. Available from: https:\/\/www.cochrane.org\/handbook."},{"key":"27448_CR26","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.12659\/MSM.904957","volume":"23","author":"XH Fang","year":"2017","unstructured":"Fang XH, Guan SY, Tang L, Tao FB, Zou Z, Wang JX, et al. Effect of Short Message Service on Management of Pulmonary Tuberculosis Patients in Anhui Province, China: A Prospective, Randomized, Controlled Study. Med Sci Monit. 2017;23:2465\u20139. https:\/\/doi.org\/10.12659\/MSM.904957.","journal-title":"Med Sci Monit"},{"issue":"9","key":"27448_CR27","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1089\/tmj.2019.0190","volume":"26","author":"P Guo","year":"2020","unstructured":"Guo P, Qiao W, Sun Y, Liu F, Wang C. Telemedicine Technologies and Tuberculosis Management: A Randomized Controlled Trial. Telemed E-Health. 2020;26(9):1150\u20136. https:\/\/doi.org\/10.1089\/tmj.2019.0190.","journal-title":"Telemed E-Health"},{"issue":"9","key":"27448_CR28","doi-asserted-by":"publisher","first-page":"e1001876","DOI":"10.1371\/journal.pmed.1001876","volume":"12","author":"X Liu","year":"2015","unstructured":"Liu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, et al. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial. PLOS Med. 2015;12(9):e1001876. https:\/\/doi.org\/10.1371\/journal.pmed.1001876.","journal-title":"PLOS Med"},{"issue":"10430","key":"27448_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(23)02270-5","volume":"403","author":"X Wei","year":"2024","unstructured":"Wei X, Hicks JP, Zhang Z, Haldane V, Pasang P, Li L, et al. Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial. Lancet. 2024;403(10430):913\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(23)02270-5.","journal-title":"Lancet"},{"issue":"5","key":"27448_CR30","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1016\/S2214-109X(23)00068-2","volume":"11","author":"X Liu","year":"2023","unstructured":"Liu X, Thompson J, Dong H, Sweeney S, Li X, Yuan Y, et al. Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial. Lancet Glob Health. 2023;11(5):e693\u2013703. https:\/\/doi.org\/10.1016\/S2214-109X(23)00068-2.","journal-title":"Lancet Glob Health"},{"key":"27448_CR31","unstructured":"Farooqi RJ, Ashraf S, Zaman M. The role of mobile SMS reminders in improving drug compliance in patients receiving anti-TB treatment from DOTS program. J Postgrad Med Inst. 2017;31(2):156\u201375 http:\/\/www.jpmi.org.pk\/index.php\/jpmi\/article\/view\/2037\/1854."},{"key":"27448_CR32","doi-asserted-by":"publisher","unstructured":"Mohammed S, Glennerster R, Khan AJ. Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial. Gao L, editor. PLOS ONE. 2016;11(11):e0162944. https:\/\/doi.org\/10.1371\/journal.pone.0162944.","DOI":"10.1371\/journal.pone.0162944"},{"key":"27448_CR33","doi-asserted-by":"publisher","first-page":"e53411","DOI":"10.2196\/53411","volume":"12","author":"P Kumwichar","year":"2024","unstructured":"Kumwichar P, Prappre T, Chongsuvivatwong V. Tuberculosis Treatment Compliance Under Smartphone-Based Video-Observed Therapy Versus Community-Based Directly Observed Therapy: Cluster Randomized Controlled Trial. JMIR MHealth UHealth. 2024;12:e53411. https:\/\/doi.org\/10.2196\/53411.","journal-title":"JMIR MHealth UHealth"},{"key":"27448_CR34","unstructured":"Gupta A, Bhardwaj AK, Singh H, Kumar S, Gupta R. Effect of \u2018mHealth\u2019Interventions on adherence to treatment and outcomes in Tuberculosis patients of district Shimla, Himachal Pradesh, India: A Randomised Control Trial. Indian J. Prev. Soc. Med. 2020;51(3):126\u201335. https:\/\/www.researchgate.net\/profile\/Harshvardhan-Singh-35\/publication\/365701945_Effect_of_%27mHealth%27_Interventions_on_adherence_to_treatment_and_outcomes_in_Tuberculosis_patients_of_district_Shimla_Himachal_Pradesh_India_A_Randomised_Control_Trial\/links\/637f091b54eb5f547cfc51b1."},{"issue":"10485","key":"27448_CR35","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(24)02847-2","volume":"405","author":"D Jerene","year":"2025","unstructured":"Jerene D, Van Kalmthout K, Levy J, Alacapa J, Deyanova N, Dube T, et al. Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials. Lancet. 2025;405(10485):1155\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(24)02847-2.","journal-title":"Lancet"},{"key":"27448_CR36","unstructured":"WHO consolidated guidelines on tuberculosis. module 4: treatment: drug-susceptible tuberculosis treatment. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240048126. Cited 7 Jul 2025."},{"key":"27448_CR37","volume-title":"Recommendations on digital interventions for health system strengthening","author":"WHO guideline","year":"2019","unstructured":"WHO guideline. Recommendations on digital interventions for health system strengthening. Geneva: World Health Organization; 2019."},{"issue":"4","key":"27448_CR38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.26719\/2003.9.4.702","volume":"9","author":"A Mohan","year":"2003","unstructured":"Mohan A, Nassir H, Niazi A. Does routine home visiting improve the return rate and outcome of DOTS patients who delay treatment? East Mediterr Health J. 2003;9(4):702\u20138. https:\/\/doi.org\/10.26719\/2003.9.4.702.","journal-title":"East Mediterr Health J"},{"issue":"1","key":"27448_CR39","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1186\/s12889-019-7520-8","volume":"19","author":"AJ AlSahafi","year":"2019","unstructured":"AlSahafi AJ, Shah HBU, AlSayali MM, Mandoura N, Assiri M, Almohammadi EL, et al. High non-compliance rate with anti-tuberculosis treatment: a need to shift facility-based directly observed therapy short course (DOTS) to community mobile outreach team supervision in Saudi Arabia. BMC Public Health. 2019;19(1):1168. Located at: Ovid MEDLINE(R). https:\/\/doi.org\/10.1186\/s12889-019-7520-8.","journal-title":"BMC Public Health"},{"key":"27448_CR40","doi-asserted-by":"publisher","first-page":"100210","DOI":"10.1016\/j.jctube.2020.100210","volume":"22","author":"A Al-Sahafi","year":"2021","unstructured":"Al-Sahafi A, Al-Sayali MM, Mandoura N, Shah HBU, Al Sharif K, Almohammadi EL, et al. Treatment outcomes among tuberculosis patients in Jeddah, Saudi Arabia: Results of a community mobile outreach directly observed Treatment, Short-course (DOTS) project, compared to a standard facility-based DOTS: A randomized controlled trial. J Clin Tuberc Mycobact Dis. 2021;22:100210. https:\/\/doi.org\/10.1016\/j.jctube.2020.100210.","journal-title":"J Clin Tuberc Mycobact Dis"},{"key":"27448_CR41","doi-asserted-by":"publisher","unstructured":"Sekandi JN, Kasiita V, Onuoha NA, Zalwango S, Nakkonde D, Kaawa-Mafigiri D et al. Stakeholders\u2019 Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study. JMIR MHealth UHealth. 2021;9(10):e27131. Located at: Ovid MEDLINE(R). https:\/\/doi.org\/10.2196\/27131.","DOI":"10.2196\/27131"},{"issue":"2","key":"27448_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4046\/trd.2022.0148","volume":"86","author":"MF Sazali","year":"2023","unstructured":"Sazali MF, Rahim SSSA, Mohammad AH, Kadir F, Payus AO, Avoi R, et al. Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model. Tuberc Respir Dis. 2023;86(2):82\u201393. https:\/\/doi.org\/10.4046\/trd.2022.0148.","journal-title":"Tuberc Respir Dis"},{"issue":"1","key":"27448_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12889-023-17561-z","volume":"24","author":"SA Abas","year":"2024","unstructured":"Abas SA, Ismail N, Zakaria Y, Yasin SM, Ibrahim K, Ismail I, et al. Enhancing tuberculosis treatment adherence and motivation through gamified real-time mobile app utilization: a single-arm intervention study. BMC Public Health. 2024;24(1):249. https:\/\/doi.org\/10.1186\/s12889-023-17561-z. PubMed PMID: 38254065; PubMed Central PMCID: PMC10801941.","journal-title":"BMC Public Health"},{"issue":"5","key":"27448_CR44","doi-asserted-by":"publisher","first-page":"e001018","DOI":"10.1136\/bmjgh-2018-001018","volume":"3","author":"R Subbaraman","year":"2018","unstructured":"Subbaraman R, De Mondesert L, Musiimenta A, Pai M, Mayer KH, Thomas BE, et al. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Health. 2018;3(5):e001018. https:\/\/doi.org\/10.1136\/bmjgh-2018-001018.","journal-title":"BMJ Glob Health"},{"key":"27448_CR45","unstructured":"Tkela MY, Sambriong M, Kapitan M. Implementation of Alarm and Pill Reminder for Medication Adherence in Tuberculosis Patients. 2025;16(01):447\u201359. https:\/\/ijhp.net\/index.php\/IJHP\/article\/download\/51\/79."},{"issue":"1","key":"27448_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12955-016-0442-6","volume":"14","author":"T Kastien-Hilka","year":"2016","unstructured":"Kastien-Hilka T, Abulfathi A, Rosenkranz B, Bennett B, Schwenkglenks M, Sinanovic E. Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis\u2013 a systematic review of global literature with focus on South Africa. Health Qual Life Outcomes. 2016;14(1):42. https:\/\/doi.org\/10.1186\/s12955-016-0442-6.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"27448_CR47","doi-asserted-by":"publisher","first-page":"2000493","DOI":"10.1183\/13993003.00493-2020","volume":"56","author":"L Ravenscroft","year":"2020","unstructured":"Ravenscroft L, Kettle S, Persian R, Ruda S, Severin L, Doltu S, et al. Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova. Eur Respir J. 2020;56(2):2000493. https:\/\/doi.org\/10.1183\/13993003.00493-2020.","journal-title":"Eur Respir J"},{"key":"27448_CR48","doi-asserted-by":"publisher","first-page":"1327971","DOI":"10.3389\/fpubh.2024.1327971","volume":"12","author":"AW Tadesse","year":"2024","unstructured":"Tadesse AW, Mganga A, Dube TN, Alacapa J, Van Kalmthout K, Letta T, et al. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants \u2013 A multicountry study. Front Public Health. 2024;12:1327971. https:\/\/doi.org\/10.3389\/fpubh.2024.1327971.","journal-title":"Front Public Health"},{"key":"27448_CR49","doi-asserted-by":"publisher","first-page":"e40167","DOI":"10.2196\/40167","volume":"2","author":"JN Sekandi","year":"2023","unstructured":"Sekandi JN, Shi W, Zhu R, Kaggwa P, Mwebaze E, Li S. Application of Artificial Intelligence to the Monitoring of Medication Adherence for Tuberculosis Treatment in Africa: Algorithm Development and Validation. JMIR AI. 2023;2:e40167. https:\/\/doi.org\/10.2196\/40167.","journal-title":"JMIR AI"},{"issue":"1","key":"27448_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12889-023-17561-z","volume":"24","author":"SA Abas","year":"2024","unstructured":"Abas SA, Ismail N, Zakaria Y, Yasin SM, Ibrahim K, Ismail I, et al. Enhancing tuberculosis treatment adherence and motivation through gamified real-time mobile app utilization: a single-arm intervention study. BMC Public Health. 2024;24(1):249. https:\/\/doi.org\/10.1186\/s12889-023-17561-z.","journal-title":"BMC Public Health"},{"key":"27448_CR51","doi-asserted-by":"publisher","unstructured":"Mohamed MS, Zary M, Kafie C, Chilala CI, Bahukudumbi S, Foster N et al. The Impact of Digital Adherence Technologies on Health Outcomes in Tuberculosis: A Systematic Review and Meta-Analysis. 2024. Available from: http:\/\/medrxiv.org\/lookup\/doi\/. https:\/\/doi.org\/10.1101\/2024.01.31.24302115. Cited 7 Jul 2025.","DOI":"10.1101\/2024.01.31.24302115"},{"issue":"3","key":"27448_CR52","first-page":"171","volume":"13","author":"AF T\u00e1rtaro","year":"2023","unstructured":"T\u00e1rtaro AF, Silva RV dos, Ara\u00fajo S, de Ramos JST, Berra ACV, Alves TZ. Digital health for treatment adherence in people with tuberculosis: a systematic review. Rev Epidemiol E Controle Infec\u00e7\u00e3o. 2023;13(3):171\u20139.","journal-title":"Rev Epidemiol E Controle Infec\u00e7\u00e3o"},{"issue":"7","key":"27448_CR53","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.3414\/ME17-05-0003","volume":"56","author":"H Abaza","year":"2017","unstructured":"Abaza H, Marschollek M. mHealth Application Areas and Technology Combinations*. A Comparison of Literature from High and Low\/Middle Income Countries. Methods Inf Med. 2017;56(7):e105\u201322. https:\/\/doi.org\/10.3414\/ME17-05-0003. Located at: Ovid MEDLINE(R. ) <\u20092017>","journal-title":"Methods Inf Med"},{"issue":"1","key":"27448_CR54","doi-asserted-by":"publisher","first-page":"348","DOI":"10.59188\/eduvest.v5i1.1541","volume":"5","author":"DWS Harahap","year":"2025","unstructured":"Harahap DWS, Andrajati R, Sari SP, Handayani D. The Factor Affecting Medication Adherence in Tuberculosis Patients: A Literature Review. Eduvest - J Univers Stud. 2025;5(1):348\u201355. https:\/\/doi.org\/10.59188\/eduvest.v5i1.1541.","journal-title":"Eduvest - J Univers Stud"},{"issue":"1","key":"27448_CR55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.15562\/bmj.v12i1.3826","volume":"12","author":"Muhammad Thesa Ghozali, Cica Tri Murani","year":"2023","unstructured":"Muhammad Thesa Ghozali, Cica Tri Murani. Relationship between knowledge and medication adherence among patients with tuberculosis: a cross-sectional survey. Bali Med J. 2023;12(1):158\u201363. https:\/\/doi.org\/10.15562\/bmj.v12i1.3826.","journal-title":"Bali Med J"},{"issue":"5","key":"27448_CR56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7475\/kjan.2018.30.5.493","volume":"30","author":"EY Jung","year":"2018","unstructured":"Jung EY, Hwang SK. Factors Related to Medication Adherence in Adult Patients with Tuberculosis. Korean J Adult Nurs. 2018;30(5):493. https:\/\/doi.org\/10.7475\/kjan.2018.30.5.493.","journal-title":"Korean J Adult Nurs"},{"issue":"12","key":"27448_CR57","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/ijerph21121662","volume":"21","author":"A Fernandes","year":"2024","unstructured":"Fernandes A, Laohaprapanon S, Nam TT, Sequeira EMDC, Le CN. Adherence to Pulmonary Tuberculosis Medication and Associated Factors Among Adults: A Cross-Sectional Study in the Metinaro and Becora Sub-Districts, Dili, Timor-Leste. Int J Environ Res Public Health. 2024;21(12):1662. https:\/\/doi.org\/10.3390\/ijerph21121662.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"27448_CR58","doi-asserted-by":"publisher","first-page":"e23294","DOI":"10.2196\/23294","volume":"23","author":"BE Thomas","year":"2021","unstructured":"Thomas BE, Kumar JV, Periyasamy M, Khandewale AS, Hephzibah Mercy J, Raj EM, et al. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers. J Med Internet Res. 2021;23(6):e23294. https:\/\/doi.org\/10.2196\/23294.","journal-title":"J Med Internet Res"},{"key":"27448_CR59","unstructured":"1.1\u00a0TB incidence. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2023\/tb-disease-burden\/1-1-tb-incidence. Cited 9 Jul 2025."},{"key":"27448_CR60","unstructured":"The End TB Strategy. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/the-end-tb-strategy. Cited 7 Jul 2025."},{"key":"27448_CR61","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Violante M, Hern\u00e1ndez\u2010Medrano AJ, Cervantes\u2010Arriaga A. The Importance of Standardized Assessment. Mov Disord Clin Pract. 2024;11(S3). https:\/\/doi.org\/10.1002\/mdc3.14085.","DOI":"10.1002\/mdc3.14085"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27448-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27448-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27448-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:16:51Z","timestamp":1784193411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27448-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27448"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27448-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8383251\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2167"}}